Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04802304 · ClinicalTrials.gov registry record · NA

Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan

A NA study, sponsored by RAND.

Completed
Registry status
NA
Development phase
233
Enrollment target

NCT04802304: Completed NA study, sponsored by RAND.

NCT04802304 is a NA study that has completed, run by RAND. The registered enrollment target is 233 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04802304, a NA study, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
233 participants
Enrollment target

Study Summary

Beyond Bias will evaluate the impact of an intervention designed to reduce family planning provider bias towards young, unmarried, and nulliparous women in Tanzania, Burkina Faso, and Pakistan. The intervention has three components: 1) a summit that includes impactful stories told to and by family planning providers that highlight the consequences of provider bias, 2) a forum for continued communication between providers, and 3) a rewards program where clinics in which providers exhibit less biased client interactions or who have improved the most towards this end will be rewarded with social recognition and a ceremony. Half of the eligible clinics in each country (233 in total) are randomly assigned to receive the intervention, while the remaining half serves as control. The objective of the evaluation is to estimate the impact of the intervention on a range of outcomes related to quality of family planning care among young, unmarried, and nulliparous women. The investigators hypothesize that the intervention will increase the share of young, unmarried, and nulliparous women who received counseling on a range of methods, counseling on long acting methods, and who received their preferred method. The investigators will collect four types of data to evaluate the intervention: 1) provider surveys, 2) mystery clients' visits, 3) direct observations of client-provider interactions, and 4) qualitative interviews with clients, providers, and implementors.

Primary Outcome

This is a measure of whether the client received family planning services on the day they came into the clinic. This will be measured from real clients using client exit surveys and using mystery clients.

Interventions

  • OTHER Beyond Bias Treatment

Trial Details

FieldValue
Enrollment Target 233 participants
Start Date 2020-09-01
Est. Completion 2022-10-14
Phase NA
RAND

78 total trials

What the finished NCT04802304 record still lists

NCT04802304 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Beyond Bias Treatment is the first listed.

NCT04802304 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04802304 about?

NCT04802304 is a clinical study titled "Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan". Beyond Bias will evaluate the impact of an intervention designed to reduce family planning provider bias towards young, unmarried, and nulliparous women in Tanzania, Burkina Faso, and Pakistan. The intervention has three components: 1) a summit that includes impactful stories told to and by family p...

What is the current status of trial NCT04802304?

This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2020-09-01. Estimated completion is 2022-10-14.

What interventions are being tested in trial NCT04802304?

The interventions under investigation include: Beyond Bias Treatment (OTHER).

Who is sponsoring clinical trial NCT04802304?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04802304's enrollment target sits among peer trials

233 463rd of 2000 higher than 1,538 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06993844 · 233 participants · Phase 1

    Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NCT07141706 · 233 participants · Phase 1

    A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

  • NCT04942717 · 234 participants · NA

    Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

  • NCT05208671 · 234 participants · NA

    Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04802304, the US trial registry maintained by the National Library of Medicine. NCT04802304 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.